FEcal Microbiota Transplantation

• Status: Unknown status
• Trial end date: 2020-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective will be to evaluate effectiveness, safety and acceptability of FMT on depressive symptoms at 2 months follow-up in SZ patients with resistant MD.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assistance Publique Hopitaux De Marseille

Criteria

Inclusion Criteria:

• patients aged 18 to 65 years

• with the current diagnosis of shizophrenia

Exclusion Criteria:

• history of lifetime FMT

• History of gut surgery